0001104659-22-059937.txt : 20220513 0001104659-22-059937.hdr.sgml : 20220513 20220513090717 ACCESSION NUMBER: 0001104659-22-059937 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 EFFECTIVENESS DATE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC CENTRAL INDEX KEY: 0001704132 IRS NUMBER: 821204449 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18415 FILM NUMBER: 22920488 BUSINESS ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001704132 XXXXXXXX 03-31-2022 03-31-2022 false Foresite Capital Management IV, LLC

900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939

13F HOLDINGS REPORT 028-18415 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 05-13-2022 0 9 357448 INFORMATION TABLE 2 infotable.xml Aclaris Therapeutics, Inc. COM 00461U105 49979 2899034 SH SOLE 2899034 0 0 Cue Health Inc. COM 229790100 1700 263578 SH SOLE 263578 0 0 Cymabay Therapeutics, Inc. COM 23257D103 5558 1787094 SH SOLE 1787094 0 0 Kinnate Biopharma Inc. COM 49705R105 108903 9671643 SH SOLE 9671643 0 0 Kura Oncology, Inc. COM 50127T109 29747 1849947 SH SOLE 1849947 0 0 Lyell Immunopharma, Inc. COM 55083R104 67075 13282181 SH SOLE 13282181 0 0 Nurix Therapeutics, Inc. COM 67080M103 14441 1030798 SH SOLE 1030798 0 0 Pharvaris N.V. COM N69605108 59155 3261926 SH SOLE 3261926 0 0 Quantum-Si Incorporated COM CL A 74765K105 20890 4463619 SH SOLE 4463619 0 0